Faculty Affairs News Supporting and Celebrating Faculty Success at UTMB
A Message from the Senior Vice President and Provost (interim):
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Health Education Center (HEC)
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Events
News and Awards
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
Research and Innovations
News and Events
Updates from the Office of Innovation
Welcome, Prenaital!
Prenaital, a Denmark start-up company that develops AI models to improve diagnostics of pregnant women, and the Consulate General of Denmark-Houston visited UTMB on February 11, 2025.
UTMB's AI Team, OB/GYN physicians, and the Office of Innovation provided feedback and collaboration opportunities with UTMB faculty to better understand the US market for their companies’ diagnostic solutions.
Announcing the UTMB Innovation Advisory Board
The Office of Innovation has constituted this new group of industry leaders to advise us on commercialization opportunities for UTMB faculty and technologies.
Murali Gopalakrishnan, PhD – Abbvie
Julio Medina, PhD – R2M Pharma
Jakob Dupont, MD - Soffinova
William McKeon – Texas Medical Center
Pei Yong Shi, PhD – GSK
James Galbraith – MAPA Law Firm
Sanja Sever, PhD – Vice President for Drug Discovery and Director of the Sealy Institute for Drug Discovery, UTMB
We are thrilled to announce our inaugural UTMB Innovation summit. This event will bring together a dynamic community of innovators, entrepreneurs, researchers, and investors. We plan to discuss the fast-growing Biotech economy in Texas, current investment themes and opportunities and market outlook.
June Library classes are available to support faculty with scholarly publishing. Register for "Identifying Predatory Journals and Conferences" and "I've Written It, Now Where Do I Publish It?"
Join us for a vibrant and interactive session where UTMB faculty share their impactful work across Asia.
Do you have an item for our Faculty Affairs newsletter? Please provide your submissions by June 20 to be considered for publication in the next edition.
